Language

Google Translate Disclaimer

A number of pages on the Government of Saskatchewan's website have been professionally translated in French. These translations are identified by a yellow box in the right or left rail that resembles the link below. The home page for French-language content on this site can be found at:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

Software-based translations do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language. The Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Mpox (monkeypox)

Confirmed cases of mpox (monkeypox) in Saskatchewan will be reported to the Public Health Agency of Canada per routine reporting practices.

Mpox is a rare disease that is caused by infection with mpox virus.

Mpox does not spread easily from person to person. It is spread through close skin-to-skin contact with someone who has the disease, including touching their bodily fluids and coming into contact with infected objects, such as unwashed bedding and clothing.

Vaccines are now available for individuals who are considered high risk to prevent infection.

Further information on mpox is available:

What You Need to Know

Call HealthLine 811 for assessment of risk and referral. The signs and symptoms of mpox typically include fever, headache, muscle aches, exhaustion and swollen lymph nodes, and a rash that often appears within a few days after symptoms such as fever develop.

Risk to Canadians

  • The Public Health Agency of Canada (PHAC) is working with provinces and territories to investigate reports of potential cases of mpox in Canada.
  • The risk to Canadians remains low.
  • Mpox is commonly found in parts of Central and West Africa. Since 2022, cases have been reported in several countries outside Africa, including Canada.
  • Outside of Africa, including in Canada, sexual contact with a case is the most commonly reported risk factor. Having multiple sexual partners may increase your overall risk of infection.
  • People travelling to Africa and other parts of the world with confirmed cases of mpox may be at risk if attending gatherings or events that entail close, prolonged and frequent skin-to-skin contact with other people.

Vaccine Information

The IMVAMUNE® Smallpox and Mpox Vaccine is available for those who meet the eligibility criteria. For more details on eligibility, view/download the following information sheet (available in English and French):

We need your feedback to improve saskatchewan.ca. Help us improve